Motor neurone disease
Also known as: Motor neuron disease, MND, Amyotrophic lateral sclerosis, ALS, Lou Gehrig disease
Motor neurone disease (MND) comprises a spectrum of progressive neurodegenerative disorders involving motor neurone attrition, resulting in muscular atrophy, weakness, and sometimes bulbar or respiratory impairment. Amyotrophic lateral sclerosis (ALS) represents the most common phenotype. Primary management involves multidisciplinary neurological oversight, respiratory and nutritional intervention, and early integration of neuropalliative care. Within the Chinese medicine framework, assessment may provide a structure for addressing individual comfort concerns, though identified patterns do not correlate with biomedical diagnosis or prognostic trajectory. The cited evidence demonstrates no MND-specific efficacy for acupuncture or herbal medicine. A systematic review of fatigue in Parkinson’s disease reported no significant benefit for acupuncture over sham, and these findings are non-generalisable to MND. Traditional modalities serve solely as practitioner reference frameworks and are not established interventions for the preservation of motor function, improvement of deglutition, extension of survival, or as substitutes for standard medical care.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Schedule abbreviated activities with frequent rest intervals and utilise prescribed mobility aids to prevent physical exertion reaching the point of exhaustion.
- •Adhere strictly to dietary, fluid consistency, and communication strategies prescribed by a speech pathologist; immediately report any episodes of coughing during deglutition.
- •Maintain rigorous monitoring of body mass and meal tolerance in coordination with the clinical team; engage dietitian services in lieu of adopting restrictive nutritional regimens.
- •Initiate early discussions regarding comfort objectives, caregiver respite, and advance care preferences with MND and neuropalliative specialist teams.
Cautions & Contraindications
- •Do not substitute acupuncture or herbs for neurological treatment, respiratory support, nutritional interventions or early neuropalliative care. Source [3] supports early neuropalliative involvement; it does not evaluate Chinese-medicine safety or efficacy.[]
- •Do not administer oral herbal products when swallowing is unsafe, and do not put herbal products through a feeding tube without pharmacist and treating-team approval. This is a general safety precaution not specifically addressed in the supplied abstracts.[]
- •Defer acupuncture during respiratory instability, acute infection, dehydration or unexplained rapid deterioration. Avoid deep thoracic needling, particularly in people with wasting or respiratory weakness; check bleeding risk and skin integrity. These technical precautions are not established by source [3].[]
- •Do not extrapolate Parkinson’s exercise or acupuncture findings to MND, or implement blood-flow-restriction training on the basis of the supplied stroke protocol. Source [1] concerns Parkinson’s disease and source [4] reports a protocol, not patient outcome results.[,]
When to reassess or seek care again
If an adjunctive trial is agreed, review after 2–4 weeks or sooner after any adverse effect. Record one or two patient-prioritised outcomes, such as cramp frequency, pain on a 0–10 scale, sleep disruption and treatment burden. Coordinate monitoring of weight, swallowing and respiratory function with the MND team. Stop if there is no meaningful comfort benefit, treatment adds fatigue or burden, or adverse effects occur. New bulbar or respiratory symptoms, weight loss or unexpectedly rapid deterioration require prompt medical reassessment rather than a revised TCM pattern alone.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Clinical parkinsonism & related disorders · 2026
- Movement disorders clinical practice · 2026
- Clinical medicine (London, England) · 2024
- BMJ open · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
